Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
12 p, 524.6 KB Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells / Huyveneers, Laura E. P. (University Medical Center Utrecht) ; Bruns, Anke (University Medical Center Utrecht) ; Stam, Arjen (University Medical Center Utrecht) ; Ellerbroek, Pauline (University Medical Center Utrecht) ; de Jong, Dorien (University Medical Center Utrecht) ; Nagy, Noémi A. (University Medical Center Utrecht) ; Gumbs, Stephanie B. H. (University Medical Center Utrecht) ; Tesselaar, Kiki (University Medical Center Utrecht) ; Bosman, Kobus (University Medical Center Utrecht) ; Salgado, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Hütter, Gero (DKMS CC) ; Brosens, Lodewijk A. A. (University Medical Center Utrecht) ; Kwon, Mi (Hospital General Universitario Gregorio Marañón) ; Diez Martin, Jose (Hospital General Universitario Gregorio Marañón) ; van der Meer, Jan T. M. (Amsterdam UMC) ; de Kort, Theun M. (Leiden University Medical Center) ; Sáez-Cirión, Asier (Université Paris Cité) ; Schulze zur Wiesch, Julian (UMC Hamburg-Eppendorf) ; Boelens, Jaap Jan (Memorial Sloan Kettering Cancer Center) ; Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Kuball, Jurgen (University Medical Center Utrecht) ; Wensing, Annemarie M. J. (University Medical Center Utrecht) ; Nijhuis, Monique (University Medical Center Utrecht)
Allo-HSCT with CCR5Δ32/Δ32 donor cells is the only curative HIV-1 intervention. We investigated the impact of allo-HSCT on the viral reservoir in PBMCs and post-mortem tissue in two patients. IciS-05 and IciS-11 both received a CCR5Δ32/Δ32 allo-HSCT. [...]
2022 - 10.3390/v14092069
Viruses, Vol. 14 (september 2022)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.